Education
About Us
Working with TipRanks
Follow Us
Celon Pharma SA (DE:8RP)
FRANKFURT:8RP
Cpl409116
Rheumatoid Arthritis
Phase II
Completed
Efficacy and Safety Study Comparing CPL409116 to Placebo in Participants With Active Rheumatoid Arthritis
May 04, 2022
―
Cpl500036 - Low Dose, Cpl500036 - High Dose
Parkinson Disease, Dyskinesia, Medication-Induced
Phase II
Completed
Efficacy, Safety and Pharmacokinetic Study of CPL500036 in Patients with Levodopa Induced Dyskinesia
Feb 17, 2022
―
Cpl500036 - Low Dose, Cpl500036 - High Dose
Schizophrenia
Phase II
Completed
Efficacy, Safety and Pharmacokinetics Study of CPL500036 (PDE10A Inhibitor) in Patients With Schizophrenia
Feb 09, 2022
―
Cpl207280
Type 2 Diabetes
Phase II
Unknown
Efficacy, Safety and Pharmacokinetics Study of CPL207280 After 2-weeks Administration in Subjects With Type 2 Diabetes
Feb 04, 2022
―
Cpl409116
Healthy
Phase I
Completed
Safety and Pharmacokinetics of JAK/ROCK Inhibitor in Healthy Volunteers
Nov 27, 2020
―
Cpl207280, Metformin Hydrochloride 750 Mg
Healthy Volunteers
Phase I
Completed
Safety and Pharmacokinetics Study of CPL207280 Compound in Healthy Volunteers.
Nov 06, 2020
―
Cpl304110
Endometrial Cancer, Bladder Cancer, Gastric Cancer, Sarcoma, Cholangiocarcinoma, Squamous Non-Small Cell Lung Cancer, Other Solid Tumours
Phase I
Recruiting
Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies
Oct 31, 2019
―
Esketamine Dpi - Low Dose, Esketamine Dpi - Medium Dose, Esketamine Dpi - High Dose
Major Depressive Disorder
Phase II
Completed
Efficacy, Safety and Pharmacokinetic Study of Inhaled Esketamine in Treatment-resistant Depression
May 21, 2019
―
Esketamine Dpi - Low Dose, Esketamine Dpi - Medium Dose, Esketamine Dpi - High Dose
Bipolar Depression
Phase II
Completed
Efficacy, Safety and Pharmacokinetic Study of Inhaled Esketamine in Treatment-resistant Bipolar Depression
May 21, 2019
―
Cpl500036 Compound
Healthy Volunteers
Phase I
Completed
Safety and Pharmacokinetics Study of CPL500036 Compound in Healthy Volunteers
Mar 11, 2019
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Celon Pharma SA (8RP) have in its pipeline
8RP is currently developing the following drugs: Cpl409116, Cpl500036 - Low Dose, Cpl500036 - High Dose, Cpl500036 - Low Dose, Cpl500036 - High Dose. These drug candidates are in various stages of clinical development as the company works toward FDA approval.